Quick Answer
INTEGRA LIFESCIENCES HOLDINGS CORP reported Total Revenue of $1.64 billion for fiscal year 2025.
INTEGRA LIFESCIENCES HOLDINGS CORP Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $1.64B | +1.5% |
| 2024 | $1.61B | +4.5% |
| 2023 | $1.54B | -1.0% |
| 2022 | $1.56B | +1.0% |
| 2021 | $1.54B | +12.4% |
| 2020 | $1.37B | -9.6% |
| 2019 | $1.52B | +3.1% |
| 2018 | $1.47B | +23.9% |
| 2017 | $1.19B | +19.8% |
| 2016 | $992.08M | +12.4% |
| 2015 | $882.73M | +10.8% |
| 2014 | $796.72M | +14.3% |
| 2013 | $696.83M | -16.1% |
| 2012 | $830.87M | +6.5% |
| 2011 | $780.08M | +6.6% |
| 2010 | $732.07M | +7.3% |
| 2009 | $682.49M | +4.3% |
| 2008 | $654.60M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $402.06M | +5.6% | -3.3% |
| June 30, 2025 | $415.61M | -0.6% | +8.6% |
| March 31, 2025 | $382.65M | +3.7% | +0.5% |
| September 30, 2024 | $380.83M | -0.4% | -8.9% |
| June 30, 2024 | $418.18M | +9.7% | +13.4% |
| March 31, 2024 | $368.87M | -3.1% | -3.5% |
| September 30, 2023 | $382.42M | -0.7% | +0.3% |
| June 30, 2023 | $381.27M | -4.2% | +0.1% |
- INTEGRA LIFESCIENCES HOLDINGS CORP showed an increase of +1.5% in Total Revenue compared to the prior fiscal year.
- Over the 2008–2025 period, INTEGRA LIFESCIENCES HOLDINGS CORP’s total revenue has grown by 149.8% (from $654.60 million to $1.64 billion).
- The most recent figure is from INTEGRA LIFESCIENCES HOLDINGS CORP’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: